BeOne Medicines
ONC
#670
Rank
โ‚น3.751 T
Marketcap
โ‚น33,160
Share price
-2.40%
Change (1 day)
17.94%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): โ‚น434.74

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น459.02. In 2025 the company made an earnings per share (EPS) of โ‚น260.52 an increase over its 2024 EPS that were of -โ‚น595.48.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น434.7466.87%
2025โ‚น260.52-143.75%
2024-โ‚น595.48
2022-โ‚น1,86128.21%
2021-โ‚น1,451-19.96%
2020-โ‚น1,81320.81%
2019-โ‚น1,50131.52%
2018-โ‚น1,141417.57%
2017-โ‚น220.52-37.16%
2016-โ‚น350.95158.95%
2015-โ‚น135.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น25.77-105.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น90.66-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA